Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
USD Partners LP and and USD Terminals Canada ULC’s Amendment of Revolving Credit Agreement
Gibson, Dunn & Crutcher LLP served as legal advisor to the Partnership and Lazard acted as financial advisor to the Partnership. On November 21, 2023, USD...